Bespoke Extracts (BSPK) EBIT (2017 - 2025)
Bespoke Extracts (BSPK) has disclosed EBIT for 9 consecutive years, with -$53891.0 as the latest value for Q3 2025.
- Quarterly EBIT rose 79.47% to -$53891.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$640301.0 through Sep 2025, up 40.74% year-over-year, with the annual reading at -$994628.0 for FY2024, 32.43% up from the prior year.
- EBIT hit -$53891.0 in Q3 2025 for Bespoke Extracts, up from -$161958.0 in the prior quarter.
- In the past five years, EBIT ranged from a high of -$53891.0 in Q3 2025 to a low of -$1.1 million in Q3 2022.
- Historically, EBIT has averaged -$409465.9 across 5 years, with a median of -$296192.0 in 2023.
- Biggest YoY gain for EBIT was 90.67% in 2021; the steepest drop was 83.75% in 2021.
- Year by year, EBIT stood at -$67933.0 in 2021, then tumbled by 1226.57% to -$901176.0 in 2022, then surged by 70.6% to -$264914.0 in 2023, then soared by 32.39% to -$179114.0 in 2024, then soared by 69.91% to -$53891.0 in 2025.
- Business Quant data shows EBIT for BSPK at -$53891.0 in Q3 2025, -$161958.0 in Q2 2025, and -$245338.0 in Q1 2025.